Crisprtx.com — Website Analysis

crisprtx.com has a global rank of #268,438 with an estimated 29 daily visitors. Based on current traffic levels, the domain is valued at approximately $26,077.

The site runs on a .com (commercial) domain with primary IP address 162.159.27.124, an active HTTPS configuration. Its homepage is titled “Home | CRISPR Therapeutics”.

crisprtx.com was first registered on 2013-05-02 through Network Solutions, LLC.

Users commonly reach crisprtx.com by searching for "corporate governance", "corporate enforcement authority", "corporate health ireland", "corporate", "corporate social responsibility".

People searching for these terms often visit crisprtx.com:

Based on our analysis, crisprtx.com implements HTTPS encryption and scores 0% on security headers. There is room for improvement in security configuration.

crisprtx.com is missing 5 of 5 recommended security headers (Strict-Transport-Security, Content-Security-Policy, X-Content-Type-Options, X-Frame-Options, X-XSS-Protection). This leaves visitors more exposed to browser-based attacks.

All values are estimates based on publicly available traffic data.

crisprtx.com ranks #268,438 globally. While outside the top 100k, the site maintains an active presence with regular visitors.

With its current visitor volume, crisprtx.com has moderate revenue potential. Niche sites at this level often outperform estimates through targeted advertising or affiliate partnerships.

These are the websites closest to crisprtx.com in global traffic ranking.

Active since 2013 (12 years), crisprtx.com has a decade-plus track record — a sign of a stable, established web presence.

crisprtx.com uses corporate governance, corporate enforcement authority, corporate health ireland, corporate, corporate social responsibility in its technology stack.

Connection
Content-Encoding
Content-Type
Date
Link
Referrer-Policy
Server
Vary
X-Powered-By
X-Robots-Tag

Active since 2013 (12 years), crisprtx.com has a decade-plus track record — a sign of a stable, established web presence.